Sinclair Pharma (SPH) Share Price, News & Analysis

Company Overview

Sinclair Pharma plc, a specialty pharmaceutical company, engages in the manufacture, commercialization, and sale of dermatological products worldwide. It provides Silhouette Soft, a resorbable poly-L-lactic acid(PLLA)/PLGA suture with bi-directional resorbable cones for skin repositioning and tightening; and Ellansé, which offers dermal fillers. The company also provides Perfectha for wrinkle correction, facial contouring, and volume restoration; and Sculptra designed to stimulate collagen growth. It serves healthcare providers and plastic surgeons. The company was formerly known as Sinclair IS Pharma plc and changed its name to Sinclair Pharma plc in December 2015. Sinclair Pharma plc was founded in 1971 and is headquartered in London, the United Kingdom.

Key Stats

• Today's Range: N/A
• 50-Day Range: 31.80 to 31.80
• 52-Week Range: N/A
• Volume: 373,221 shs
• Average Volume: 3.30 million shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SPH Stock Analysis - Frequently Asked Questions

How do I buy shares of Sinclair Pharma?

Shares of SPH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Sinclair Pharma own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Sinclair Pharma investors own include Vectura Group (VEC), Bristol-Myers Squibb (BMY), Energy Transfer (ET), Hikma Pharmaceuticals (HIK), Jack in the Box (JACK), Merck & Co., Inc. (MRK) and Transocean (RIG).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Drug Manufacturers - Major
• Sub-Industry: N/A
• Current Symbol: LON:SPH
• CUSIP: N/A
• CIK: N/A
• Web: www.sinclairispharma.com
• Phone: +44-20-74676920
• Fax: N/A
• Employees: 2,021
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A